Apollo Endosurgery (APEN) Misses Q4 EPS by 47c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. NVDA
3. SBUX
4. SPY
5. GOOGL
6. APLD
7. USO
8. STZ
9. AGNT
10. ORCL

Go back to Apollo Endosurgery (APEN) Misses Q4 EPS by 47c, Revenues Beat

Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2018 Results

March 18, 2019 8:00 AM EDT

Conference Call to Discuss Results Today at 7:30 a.m. CT / 8:30 a.m. ET

AUSTIN, Texas--(BUSINESS WIRE)-- Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the fourth quarter and year ended December31, 2018.

Highlights

Fourth quarter ESS revenue contributed 64% of continuing product sales and increased 46% ESS revenue for the full year 2018 of $23.4 million increased 42% compared to 2017 Sale of the Surgical product line completed on... More